Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
This study is currently recruiting participants.
Study NCT00667121
Information provided by National Cancer Institute (NCI)
First Received: April 24, 2008
Last Updated: August 4, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
